Split History
ABIO split history picture
ARCA biopharma (ABIO) has 4 splits in our ABIO split history database. The first split for ABIO took place on January 28, 2009. This was a 1 for 20 reverse split, meaning for each 20 shares of ABIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split. ABIO's second split took place on March 05, 2013. This was a 1 for 6 reverse split, meaning for each 6 shares of ABIO owned pre-split, the shareholder now owned 1 share. For example, a 50 share position pre-split, became a 8.33333333333333 share position following the split. ABIO's third split took place on September 04, 2015. This was a 1 for 7 reverse split, meaning for each 7 shares of ABIO owned pre-split, the shareholder now owned 1 share. For example, a 8.33333333333333 share position pre-split, became a 1.19047619047619 share position following the split. ABIO's 4th split took place on April 04, 2019. This was a 1 for 18 reverse split, meaning for each 18 shares of ABIO owned pre-split, the shareholder now owned 1 share. For example, a 1.19047619047619 share position pre-split, became a 0.0661375661375661 share position following the split.

When a company such as ARCA biopharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ABIO split history from start to finish, an original position size of 1000 shares would have turned into 0.0661375661375661 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, presented on a split-history-adjusted basis factoring in the complete ABIO split history. ABIO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/25/2014
End date: 06/21/2024
Start price/share: $181.44
End price/share: $3.50
Dividends collected/share: $0.00
Total return: -98.07%
Average Annual Total Return: -32.63%
Starting investment: $10,000.00
Ending investment: $192.81
Years: 10.00
ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. According to our ABIO split history records, ARCA biopharma has had 4 splits.
Date Ratio
01/28/20091 for 20
03/05/20131 for 6
09/04/20151 for 7
04/04/20191 for 18
ABIO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ABMD Split History
ABT Split History
ABV Split History
ABVC Split History
ACER Split History
ACET Split History
ACHC Split History
ACHV Split History
ACON Split History
ACOR Split History

Also explore: ABIO shares outstanding history

Email EnvelopeFree ABIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Crown Electrokinetics Corp. (CRKN)
Medalist Diversified REIT, Inc. (MDRR)
Medalist Diversified REIT, Inc. (MDRR)
Qilian International Holding Group Limited (QLI)
Bluejay Diagnostics, Inc. (BJDX)
Atara Biotherapeutics, Inc. (ATRA)
GRI Bio, Inc. (GRI)
Williams-Sonoma, Inc. (WSM)
Workhorse Group Inc. (WKHS)
Virgin Galactic Holdings, Inc. (SPCE)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ABIO Insider Buying

ABIO Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.